Dr Sade Mokuolu, group compliance manager, Watson-Marlow Fluid Technology Group, examines the importance of risk assessment in qualifying SU components to ensure global adoption continues at an accelerated pace.
In this article, Dr Frank Binder, VP of global supply chain management at Santen and keynote speaker at NEXUS '17 in Barcelona, discusses the challenges and opportunities that serialisation presents to mid-sized companies.
Strategic outsourcing is trending within the pharmaceutical industry with companies relying on trusted and preferred suppliers in an integrated supply model, notes Justin Schroeder, executive director at PCI Pharma Services
Thanks to ongoing research and development in pharmaceuticals, the sector is benefitting from ongoing innovation which is helping break new boundaries in healthcare. Lu Rahman explains.
Jean-Marc Bobée, former director, industrial anti-counterfeiting strategy at Sanofi, outlines global and local traceability concepts and their individual ‘security to cost’ ratios, highlighting the need for a standardised global serialisation
In this article, Mark Usher of Solidsoft Reply, explains the challenges of deploying multiple connected national systems for the large-scale European pharmaceutical industry.
John Culkin, director of information management, Crown Records Management, reveals why pharma companies should still prepare for the EU GDPR regardless of Brexit.
Dr Charles Kettler, director Natoli Scientific analyses common sticking and picking issues in tablet manufacturing and how a little homework can go a long way in avoiding potential issues before they arise.
An expensive cholesterol drug, evolocumab, which is prescribed on the NHS, is claimed to do nothing to prevent fatal heart attacks and strokes and a coalition of doctors have called for it to be withdrawn from use.
